Esther Ndungo

2.2k citations

20 papers · 1.5k indexed · 1 hit paper · h-index 14

Co-authors: Christian Wolfrum Markus Stoffel Kartik ChandranGang WangMuthusamy Jayaraman Kallanthottathil G. Rajeev Tracy Zimmermann Tomoko Nakayama
Topics: Viral gastroenteritis research and epidemiology (12 papers)Escherichia coli research studies (10 papers)Viral Infections and Outbreaks Research (8 papers)
Cited by: Infectious Diseases Endocrinology Cancer Research
Journals: Journal of Biological Chemistry The EMBO Journal Nature Biotechnology
Partner nations: United States Switzerland Netherlands

In The Last Decade

Esther Ndungo

19 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms and optimization of in vivo delivery of lipophilic siRNAs

2007 771 citations Christian Wolfrum, K. N. Jayaprakash et al. Nature Biotechnology profile →

Peers

Countries citing papers authored by Esther Ndungo

Since Specialization

Citations

This map shows the geographic impact of Esther Ndungo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Ndungo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Ndungo more than expected).

Fields of papers citing papers by Esther Ndungo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Ndungo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Ndungo. The network helps show where Esther Ndungo may publish in the future.

Co-authorship network of co-authors of Esther Ndungo

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Ndungo. A scholar is included among the top collaborators of Esther Ndungo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Ndungo. Esther Ndungo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate 2024 ·npj Vaccines ·(unknown),(unknown),(unknown),Shannon J. Heine,(unknown),Esther Ndungo,Neeraj Kapoor,Edwin V. Oaks,Jeff Fairman,Marcela F. Pasetti	6
2	Oral immunization with Shigella sonnei WRSs2 and WRSs3 vaccine strains elicits systemic and mucosal antibodies with functional anti-microbial activity 2023 ·mSphere ·Shikha Shrivastava,(unknown),Esther Ndungo,Dilara Islam,Yuanyuan Liang,Robert W. Frenck,Marcela F. Pasetti	0
3	A Novel Shigella O-Polysaccharide–IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Shigella Serotypes 2023 ·mSphere ·(unknown),Neeraj Kapoor,(unknown),(unknown),(unknown),Esther Ndungo,Edwin V. Oaks,Jeff Fairman,Marcela F. Pasetti	8
4	Systems approach to define humoral correlates of immunity to Shigella 2022 ·Cell Reports ·Biana Bernshtein,Esther Ndungo,Deniz Cizmeci,(unknown),Pavol Kováč,Meagan Kelly,Dilara Islam,Edward T. Ryan,Karen L. Kotloff,Marcela F. Pasetti,(unknown)	14
5	Dynamics of the Gut Microbiome in Shigella -Infected Children during the First Two Years of Life 2022 ·mSystems ·Esther Ndungo,Johanna B. Holm,(unknown),Andrea G. Buchwald,Sharon M. Tennant,Miriam K. Laufer,Marcela F. Pasetti,David A. Rasko	12
6	Mucosal Immune Profiles Associated with Diarrheal Disease Severity inShigella- and Enteropathogenic Escherichia coli-Infected Children Enrolled in the Global Enteric Multicenter Study 2022 ·mBio ·Amanda D. Buskirk,Esther Ndungo,(unknown),(unknown),William C. Blackwelder,Usman N. Ikumapayi,Bing Ma,Helen Powell,Martín Antonio,James P. Nataro,James B. Kaper,Marcela F. Pasetti	6
7	Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis 2021 ·Frontiers in Immunology ·Esther Ndungo,(unknown),Andrea G. Buchwald,(unknown),(unknown),Neeraj Kapoor,Jeff Fairman,Miriam K. Laufer,Marcela F. Pasetti	15
8	Efficient production of immunologically active Shigella invasion plasmid antigens IpaB and IpaH using a cell-free expression system 2021 ·Applied Microbiology and Biotechnology ·Neeraj Kapoor,Esther Ndungo,(unknown),(unknown),(unknown),Edwin V. Oaks,Jeff Fairman,Marcela F. Pasetti	8
9	Functional antibodies as immunological endpoints to evaluate protective immunity againstShigella 2019 ·Human Vaccines & Immunotherapeutics ·Esther Ndungo,Marcela F. Pasetti	21
10	A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge 2018 ·mSphere ·Esther Ndungo,Arlo Randall,Tracy H. Hazen,(unknown),(unknown),Xiaowu Liang,Eileen M. Barry,Karen L. Kotloff,Subhra Chakraborty,Sachin Mani,David A. Rasko,Marcela F. Pasetti	32
11	A Single Residue in Ebola Virus Receptor NPC1 Influences Cellular Host Range in Reptiles 2016 ·mSphere ·Esther Ndungo,Andrew S. Herbert,Matthijs Raaben,Gregor Obernosterer,(unknown),Emily Happy Miller,Ariel S. Wirchnianski,Jan E. Carette,Thijn R. Brummelkamp,Sean P. J. Whelan,John M. Dye,Kartik Chandran	27
12	Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies 2016 ·mBio ·Zachary A. Bornholdt,Esther Ndungo,Marnie L. Fusco,Shridhar Bale,Andrew I. Flyak,James E. Crowe,Kartik Chandran,Erica Ollmann Saphire	69
13	Novel Small Molecule Entry Inhibitors of Ebola Virus 2015 ·The Journal of Infectious Diseases ·Arnab Basu,Debra M. Mills,Daniel A. Mitchell,Esther Ndungo,John D. Williams,Andrew S. Herbert,John M. Dye,Donald T. Moir,Kartik Chandran,Jean L. Patterson,Lijun Rong,Terry L. Bowlin	44
14	Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann–Pick C1 2014 ·Virology ·Melinda Ng,Esther Ndungo,Rohit K. Jangra,Yíngyún Caì,Elena Postnikova,Sheli R. Radoshitzky,John M. Dye,Eva Ramírez de Arellano,Anabel Negredo,Gustavo Palacios,Jens H. Kuhn,Kartik Chandran	38
15	Comprehensive Functional Analysis of N-Linked Glycans on Ebola Virus GP1 2014 ·mBio ·Nicholas J. Lennemann,Bethany A. Rhein,Esther Ndungo,Kartik Chandran,Xiangguo Qiu,Wendy Maury	90
16	A Mutation in the Ebola Virus Envelope Glycoprotein Restricts Viral Entry in a Host Species- and Cell-Type-Specific Manner 2013 ·Journal of Virology ·Osvaldo Martinez,Esther Ndungo,(unknown),Emily Happy Miller,Lawrence W. Leung,Kartik Chandran,Christopher F. Basler	34
17	Ebola virus entry requires the host‐programmed recognition of an intracellular receptor 2012 ·The EMBO Journal ·Emily Happy Miller,Gregor Obernosterer,Matthijs Raaben,Andrew S. Herbert,Maïka S. Deffieu,Anuja Krishnan,Esther Ndungo,(unknown),Jan E. Carette,Ana I. Kuehne,Gordon Ruthel,Suzanne R. Pfeffer,John M. Dye,Sean P. J. Whelan,Thijn R. Brummelkamp,Kartik Chandran	253
18	Niemann-Pick C1 (NPC1)/NPC1-like1 Chimeras Define Sequences Critical for NPC1’s Function as a Filovirus Entry Receptor 2012 ·Viruses ·Anuja Krishnan,Emily Happy Miller,Andrew S. Herbert,Melinda Ng,Esther Ndungo,Sean P. J. Whelan,John M. Dye,Kartik Chandran	33
19	Foxa2 Activity Increases Plasma High Density Lipoprotein Levels by Regulating Apolipoprotein M 2008 ·Journal of Biological Chemistry ·Christian Wolfrum,Jessica J. Howell,Esther Ndungo,Markus Stoffel	59
20	Mechanisms and optimization of in vivo delivery of lipophilic siRNAsbreakdown → 2007 ·Nature Biotechnology ·Christian Wolfrum,(unknown),K. N. Jayaprakash,Muthusamy Jayaraman,Gang Wang,Rajendra K. Pandey,Kallanthottathil G. Rajeev,Tomoko Nakayama,(unknown),Esther Ndungo,Tracy Zimmermann,Victor Koteliansky,Muthiah Manoharan,Markus Stoffel	771

About Esther Ndungo

Esther Ndungo is a scholar working on Endocrinology, Infectious Diseases and Epidemiology, having authored 20 papers that have together received 1.5k indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (12 papers), Escherichia coli research studies (10 papers) and Viral Infections and Outbreaks Research (8 papers). The work is most often cited by research in Infectious Diseases (602 citations), Endocrinology (91 citations) and Cancer Research (221 citations). Esther Ndungo has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Christian Wolfrum, Markus Stoffel, Kartik Chandran, Gang Wang, Muthusamy Jayaraman, Kallanthottathil G. Rajeev, Tracy Zimmermann, Tomoko Nakayama, Victor Koteliansky and Rajendra K. Pandey. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal and Nature Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact